The focus of the seminar delivered by members of our corporate finance and life sciences teams will be the biotech sector. The speakers assisted the UK BioIndustry Association in producing its recent guide to investing in the UK Biotech sector.


  • Is AIM the ‘new Nasdaq’ for biotechs? – this session examines the positive impact of the pandemic on the biotech sector 
  • The power of AI and Data – realising the full potential of AI and data and how it can be used to drive commercial value 
  • Understanding the value of intellectual property – what to look out for when investing and how companies deploy IP to ensure competitive advantage  
  • M&A and the future of the supply chain – an insight into emerging trends

Event date